Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Klein lab, |
RCV000170602 | SCV000223154 | pathogenic | Severe congenital neutropenia | 2013-01-01 | criteria provided, single submitter | in vitro | Neutropenia patients with mutations in JAGN1 respond poorly to treatment with recombinant human G-CSF |
Ce |
RCV001092960 | SCV001249717 | pathogenic | not provided | 2019-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000144163 | SCV003525089 | uncertain significance | Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency | 2022-04-16 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 44 of the JAGN1 protein (p.His44Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with severe congenital neutropenia (PMID: 25851723, 32419428). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 156114). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
OMIM | RCV000144163 | SCV000189243 | pathogenic | Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency | 2014-09-01 | no assertion criteria provided | literature only |